代谢因子控制对牛皮患者牛皮关节炎风险的影响:使用TrinetX数据库的回顾性队列研究
Yi-Hsuan Shen1, Yu-Chen Huang2
1Department of Dermatology, Taipei Medical University, Taipei, Taiwan.
Mayo Clinic proceedings
|December 5, 2025
概括
高密度脂蛋白 (HDL) 和甘油三 (TG) 的控制不良会增加牛皮患者的牛皮关节炎 (PsA) 风险. 管理这些代谢因素可能有助于减少PsA发病率.
科学领域:
- 类风湿病学 类风湿病学
- 代谢健康 代谢健康
- 皮肤病学 皮肤病学
背景情况:
- 牛皮 (PsO) 是一种慢性炎症性疾病,患牛皮关节炎 (PsA) 的风险更高.
- 代谢因素越来越多地被认为是导致炎症的潜在因素.
- 了解代谢控制和PsA发展之间的联系对于患者管理至关重要.
研究的目的:
- 研究关键代谢因子的控制与患有牛皮的患者患牛皮性关节炎 (PsA) 的风险之间的关联.
- 为了确定显著影响PsA风险的特定代谢参数.
主要方法:
- 追溯队列研究,利用TriNetX美国协作网络的数据,截至2022年12月31日.
- 被诊断为牛皮 (PsO) 的患者根据对代谢因素的控制进行分类:低密度脂蛋白 (LDL),高密度脂蛋白 (HDL),甘油三 (TGs),血红蛋白A1c (HbA1c) 和尿酸 (UA).
- 较差的代谢控制被定义为每个因素的特定值 (例如,高血压≤40 mg/dL,高血压≥150 mg/dL,HbA1c>7%). 危险比率 (HR) 计算用于比较不良控制和充分控制组之间的PsA发病率.
主要成果:
- 高甘油 (TG ≥150 mg/dL) 和低高密度脂蛋白 (HDL ≤40 mg/dL) 与患PsA的风险增加显著相关 (HR=1.469和HR=1.339,分别).
- 较差的血糖控制 (HbA1c>7%) 也显示出与较高的PsA风险 (HR=1.144) 有显著的关联.
- 没有发现LDL (≥130 mg/dL) 或尿酸 (UA>6 mg/dL) 的控制不良与患PsA的风险之间存在显著的关联.
结论:
- 控制甘油三和高密度胆固醇水平对于可能降低牛皮 (PsO) 患者牛皮性关节炎 (PsA) 风险很重要.
- 这些发现强调了代谢健康在PsA病变发生过程中的作用.
- 进一步的研究可能会探索有针对性的代谢干预措施,以减轻PsO患者的PsA风险.
更多相关视频
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
456
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
11.0K
相关概念视频
01:29Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
382
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
382
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
161
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
161
01:11Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K